SI

Sagarkumar Ishvarbhai Patel

Active Director Director DIN 07515637
DIN 07515637 First appointment May 2016 Primary industry Business Services
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since May 2016
Shareholding value β€’β€’β€’β€’ Premium profile

About Sagarkumar Ishvarbhai Patel

Data last updated:

Sagarkumar Ishvarbhai Patel is a Director at Verminus Pharma Private Limited (since 2016). The company operates in Business Services.

DIN 07515637
Primary Designation Director
Industry Business Services
First Appointment 11 May 2016
Oldest Company Age 10 yrs

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Verminus Pharma Private Limited U74999GJ2016PTC091915
Director11 May 20162016Active

Board colleagues of Sagarkumar Ishvarbhai Patel

Directorship timeline

Open interactive timeline →
Verminus Pharma Private Limited
Premium access

Shareholding and investment profile for Sagarkumar Ishvarbhai Patel

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Sagarkumar Ishvarbhai Patel

Sagarkumar Ishvarbhai Patel currently holds 1 directorship: Verminus Pharma Private Limited (Director, since 11 May 2016).

Sagarkumar Ishvarbhai Patel was first appointed on 11 May 2016 as Director at Verminus Pharma Private Limited.

The current boards of Sagarkumar Ishvarbhai Patel's companies include Haresh Shamalbhai Patel (Verminus Pharma Private Limited), Vipulkumar Jayantilal Barot (Verminus Pharma Private Limited).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available